Rebirthel Co., Ltd.
PrivateLast Round
Series B
Dec 1, 2022
Total Funding Raised
$1.7M
Company Overview
Rebirthel Co., Ltd. is a biotechnology company that develops allogeneic T-cell immunotherapies using iPS cells to treat cancer and other immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rebirthel Co., Ltd. Comparables
Compare Rebirthel Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 83% | |
| Cartherics | 83% | |
| Neukio Biotherapeutics | 83% |
Rebirthel Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2022 | ||||
| Seed | Mar 30, 2020 |
Key People
Founding team and executive leadership
Rebirthel Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Series B |
| 株式会社ヘルスケア・イノベーション | Series B |
| Kagawa Securities Co., Ltd. | Series B |
| Nissei Capital | Series B |
| Japan Science and Technology Agency | Seed, Series B |
| Fujifilm Corporation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2025
Partnering with Eutilex to develop next-generation CAR-T therapies.
- Mar 30, 2020
Secured funding from Japan Science and Technology Agency.
Rebirthel Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rebirthel Co., Ltd.'s valuation, stock price, and market status.
Is Rebirthel Co., Ltd. a public or private company?
Rebirthel Co., Ltd. is a private company.
What is the current stock price of Rebirthel Co., Ltd.?
Rebirthel Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Rebirthel Co., Ltd. worth (valuation)?
Valuation information for Rebirthel Co., Ltd. is not publicly available.
Can I buy Rebirthel Co., Ltd. stock?
Rebirthel Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rebirthel Co., Ltd.'s last funding round?
Rebirthel Co., Ltd.'s most recent funding round was Series A on December 1, 2022.
Who are the main investors in Rebirthel Co., Ltd.?
Key investors in Rebirthel Co., Ltd. include Chushin Venture Capital, 株式会社ヘルスケア・イノベーション, Kagawa Securities Co., Ltd., Nissei Capital, Japan Science and Technology Agency.
Will Rebirthel Co., Ltd. IPO soon?
No public IPO plans have been announced for Rebirthel Co., Ltd..
How can I track Rebirthel Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rebirthel Co., Ltd.'s secondary market activity and sign up for updates.